Literature DB >> 11704673

Structural and functional role of threonine 112 in a superantigen Staphylococcus aureus enterotoxin B.

Matthew D Baker1, Anastassios C Papageorgiou, Richard W Titball, Julie Miller, Sarah White, Bryan Lingard, Jeong Jin Lee, David Cavanagh, Michael A Kehoe, John H Robinson, K Ravi Acharya.   

Abstract

Bacterial superantigens are potent T-cell stimulatory protein molecules produced by Staphylococcus aureus and Streptococcus pyogenes. Their superantigenic activity can be attributed to their ability to cross-link major histocompatibility complex class II molecules with T-cell receptors (TCRs) to form a tri-molecular complex. Each superantigen is known to interact with a specific V(beta) element of TCR. Staphylococcal enterotoxin B (SEB, a superantigen), a primary cause of food poisoning, is also responsible for a significant percentage of non-menstrual associated toxic shock syndrome in patients with a variety of staphylococcal infections. Structural studies have elucidated a binding cavity on the toxin molecule essential for TCR binding. To understand the crucial residues involved in binding, mutagenesis analysis was performed. Our analysis suggest that mutation of a conserved residue Thr(112) to Ser (T112S) in the binding cavity induces a selective reduction in the affinity for binding one TCR V(beta) family and can be attributed to the structural differences in the native and mutant toxins. We present a detailed comparison of the mutant structure determined at 2.0 A with the previously reported native SEB and SEB-TCR V(beta) complex structures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704673     DOI: 10.1074/jbc.M109369200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Construction of a single-chain variable-fragment antibody against the superantigen Staphylococcal enterotoxin B.

Authors:  Pawan Kumar Singh; Ranu Agrawal; Dev Vrat Kamboj; Garima Gupta; M Boopathi; Ajay Kumar Goel; Lokendra Singh
Journal:  Appl Environ Microbiol       Date:  2010-10-15       Impact factor: 4.792

2.  Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.

Authors:  Tiffany K Inskeep; Chad Stahl; Jack Odle; Judy Oakes; Laura Hudson; Kenneth L Bost; Kenneth J Piller
Journal:  Clin Vaccine Immunol       Date:  2010-06-16

3.  Construction and characterization of VL-VH tail-parallel genetically engineered antibodies against staphylococcal enterotoxins.

Authors:  Xianzhi He; Lei Zhang; Pengchong Liu; Li Liu; Hui Deng; Jinhai Huang
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

4.  Staphylococcus aureus enterotoxin C2 mutants: biological activity assay in vitro.

Authors:  Jing Hui; Yan Cao; Fang Xiao; Jin Zhang; Hui Li; Fengqing Hu
Journal:  J Ind Microbiol Biotechnol       Date:  2008-05-28       Impact factor: 3.346

5.  Staphylococcus aureus isolates encode variant staphylococcal enterotoxin B proteins that are diverse in superantigenicity and lethality.

Authors:  Petra L Kohler; Seth D Greenwood; Suba Nookala; Malak Kotb; David M Kranz; Patrick M Schlievert
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.